SOCS4 — Suppressor of Cytokine Signaling 4

SOCS4 — Suppressor of Cytokine Signaling 4

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SOCS4 — Suppressor of Cytokine Signaling 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SOCS4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Suppressor of Cytokine Signaling 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>122829</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000065171</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y257</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">c.892C>T (p.R298X)</td>
<td>Nonsense</td>
</tr>
<tr>
<td class="label">c.1045G>A (p.G349S)</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">c.678delC</td>
<td>Frameshift</td>
</tr>
<tr>
<td class="label">Promoter hypermethylation</td>
<td>Epigenetic</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>ErbB signaling</td>
</tr>
<tr>
<td class="label">STAT3</td>
<td>Cytokine signaling</td>
</tr>
<tr>
<td class="label">JAK2</td>
<td>JAK-STAT</td>
</tr>
<tr>
<td class="label">PDGFR</td>
<td>Growth factor</td>
</tr>
<tr>
<td class="label">Member</td>
<td>Evolution</td>
</tr>
<tr>
<td class="label">SOCS1</t

SOCS4 — Suppressor of Cytokine Signaling 4

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SOCS4 — Suppressor of Cytokine Signaling 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SOCS4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Suppressor of Cytokine Signaling 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>122829</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000065171</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y257</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">c.892C>T (p.R298X)</td>
<td>Nonsense</td>
</tr>
<tr>
<td class="label">c.1045G>A (p.G349S)</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">c.678delC</td>
<td>Frameshift</td>
</tr>
<tr>
<td class="label">Promoter hypermethylation</td>
<td>Epigenetic</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>ErbB signaling</td>
</tr>
<tr>
<td class="label">STAT3</td>
<td>Cytokine signaling</td>
</tr>
<tr>
<td class="label">JAK2</td>
<td>JAK-STAT</td>
</tr>
<tr>
<td class="label">PDGFR</td>
<td>Growth factor</td>
</tr>
<tr>
<td class="label">Member</td>
<td>Evolution</td>
</tr>
<tr>
<td class="label">SOCS1</td>
<td>Early divergence</td>
</tr>
<tr>
<td class="label">SOCS2</td>
<td>Early divergence</td>
</tr>
<tr>
<td class="label">SOCS3</td>
<td>Later evolution</td>
</tr>
<tr>
<td class="label">SOCS4</td>
<td>Ancient</td>
</tr>
<tr>
<td class="label">SOCS5</td>
<td>Ancient</td>
</tr>
<tr>
<td class="label">SOCS6-7</td>
<td>Later evolution</td>
</tr>
<tr>
<td class="label">Reagent</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Anti-SOCS4 (N-term)</td>
<td>WB, IHC</td>
</tr>
<tr>
<td class="label">Anti-SOCS4 (C-term)</td>
<td>IP, ICC</td>
</tr>
<tr>
<td class="label">siRNA SOCS4</td>
<td>Knockdown</td>
</tr>
<tr>
<td class="label">CRISPR sgRNA</td>
<td>Knockout</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Suppressor of Cytokine Signaling 4 (SOCS4) is a member of theSuppressor of Cytokine Signaling (SOCS) family of proteins that function as critical negative regulators of cytokine signaling pathways. Originally identified for its role in modulating cytokine receptor signaling, SOCS4 has emerged as a significant molecular player in cancer biology, inflammatory responses, and potentially neurodegenerative diseases[@alexander2001][@croker2014].

The SOCS family comprises eight members (SOCS1-7 and CIS) that share a conserved structure consisting of an N-terminal kinase inhibitory region (KIR), a central SH2 domain, and a C-terminal SOCS box. While SOCS1 and SOCS2 have been most extensively studied, SOCS4 and SOCS5 represent distinct members with unique functions in cytokine and growth factor signaling regulation[@kelley2014][@bul2014].

Gene Overview

Molecular Biology

Gene Structure

The SOCS4 gene spans approximately 25 kb on chromosome 22q13.2 and comprises multiple exons. The gene encodes a protein with the characteristic SOCS family domain architecture.

Protein Structure

SOCS4, like other SOCS proteins, contains several conserved domains:

N-Terminal Kinase Inhibitory Region (KIR)

• Approximately 50 amino acids
• Variable sequence among SOCS family members
• Critical for inhibitory function in some SOCS proteins

Central SH2 Domain

• Enables specific protein-protein interactions
• Recognizes phosphotyrosine motifs on target proteins
• Determines substrate specificity

C-Terminal SOCS Box

• Binds to the Elongin B/C complex

• Targets proteins for proteasomal degradation

Expression Pattern

SOCS4 is expressed in various human tissues:

• High expression: Lung, spleen, testis
• Moderate expression: Liver, kidney, pancreas
• Low expression: Brain, heart, skeletal muscle
• Cell-type specific: Immune cells, epithelial cells

Function

Cytokine Signaling Regulation

SOCS4 regulates multiple signaling pathways:

JAK-STAT Pathway

SOCS4 modulates this pathway by:

• Inhibiting JAK kinase activity
• Competing with STAT binding sites
• Targeting signaling components for degradation

Growth Factor Signaling

SOCS4 also regulates growth factor receptors:

• EGFR signaling: Modulates ErbB pathway activity
• IGF-1 signaling: Influences growth factor responses
• PDGF signaling: Regulates platelet-derived growth factor responses

Protein Degradation

Through its SOCS box, SOCS4 recruits proteins for ubiquitination:

• Targets activated receptors for degradation
• Removes signaling components from membrane
• Controls duration of signaling responses

Disease Associations

Cancer

SOCS4 functions as a tumor suppressor in several cancer types[@bul2014][@leten2014][@li2017]:

Breast Cancer

• SOCS4 expression is frequently downregulated
• Low SOCS4 correlates with poor prognosis
• Restoration inhibits tumor cell proliferation

Lung Cancer

• Reduced SOCS4 in lung adenocarcinoma
• Associated with advanced stage disease
• Prognostic biomarker potential

Gastric Cancer

• Frequent SOCS4 downregulation
• Promoter methylation contributes to silencing
• Tumor suppressor function

Molecular Mechanisms

SOCS4 acts through multiple mechanisms:

Neurological Disorders

While less characterized than SOCS1 and SOCS3, SOCS4 has emerging roles in neurological diseases[@qiu2015][@zhao2020][@wang2022]:

Alzheimer's Disease

• Altered SOCS4 expression in AD brain
• May contribute to neuroinflammation
• Interaction with cytokine signaling

Parkinson's Disease

• Dysregulated cytokine signaling in PD
• SOCS4 may modulate inflammatory responses
• Potential for therapeutic intervention

Neuroinflammation

SOCS4 regulates neuroinflammatory processes through[@moshage2015][@hu2018]:

• Modulation of microglial activation
• Control of pro-inflammatory cytokine production
• Balance of neuroprotective vs. damaging responses

Inflammatory Diseases

• Autoimmune disorders: Altered SOCS4 expression
• Inflammatory bowel disease: Dysregulated cytokine signaling
• Rheumatoid arthritis: Potential therapeutic target

Therapeutic Implications

Cancer Therapy

SOCS4 restoration represents a promising therapeutic approach[@zhang2016][@zhang2024]:

Gene Therapy

• AAV-mediated SOCS4 delivery
• CRISPR-based activation
• Viral vector approaches

Small Molecule Activators

• SOCS4 expression inducers
• Demethylating agents (for promoter methylation)
• Histone deacetylase inhibitors

Combination Therapy

• With chemotherapy agents
• With targeted therapies
• With immunotherapy

Neurodegeneration

Modulating SOCS4 may benefit neurodegenerative diseases[@cheng2023]:

Anti-inflammatory Approaches

• Reducing microglial activation
• Modulating cytokine storm
• Protecting neurons

Neuroprotective Strategies

• Enhancing endogenous protection
• Supporting neuron survival
• Improving brain homeostasis

Research Directions

Current Areas of Investigation

Future Therapeutic Applications

• Personalized medicine: SOCS4-based patient stratification
• Gene therapy: Restoring SOCS4 function
• Small molecule development: SOCS4-targeting drugs

Interaction Networks

Signaling Pathway Interactions

SOCS4 modulates several key signaling pathways:

• Inhibits JAK kinase activity
• Competes with STAT binding
• Promotes receptor degradation

• Modulates downstream signaling
• Controls cell survival

• Regulates cell division
• Controls differentiation

Protein Interactions

SOCS4 interacts with:

• Elongin B/C complex: For ubiquitination
• Cullin proteins: E3 ligase component
• Rbx1: RING-box protein
• Tyrosine-phosphorylated receptors: Direct binding

Clinical Considerations

Biomarker Potential

SOCS4 expression has biomarker potential in:

• Cancer prognosis: Low expression = poor prognosis
• Treatment response: Predictive of therapy response
• Disease progression: Marker of disease activity

Therapeutic Development

Approaches targeting SOCS4:

Research Methods

Detection Methods

• qPCR: mRNA expression analysis
• Western blot: Protein levels
• Immunohistochemistry: Tissue localization
• Sequencing: Genetic analysis

Experimental Models

• Cell lines: Cancer cell models
• Mouse models: Knockout and transgenic
• Patient samples: Tumor and tissue banks

Summary

SOCS4 represents an important regulator of cytokine and growth factor signaling with emerging roles in cancer and neurological diseases. Its tumor suppressor function and regulation of inflammatory responses make it a promising therapeutic target. Understanding SOCS4 biology provides opportunities for:

• Cancer diagnostics and prognosis
• Targeted therapy development
• Biomarker identification
• Personalized treatment approaches

Pathogenic Variants

Several disease-associated SOCS4 variants have been identified:

Clinical Testing

SOCS4 can be assessed through multiple modalities:

• Sequencing: Targeted NGS panels for cancer genes
• Methylation analysis: MSP and bisulfite sequencing
• Expression analysis: qRT-PCR, RNA-seq
• Protein detection: IHC, Western blot

Mechanism of Action

SOCS Box Function

The SOCS box is critical for SOCS4 function:

Substrate Specificity

Unlike SOCS1 and SOCS3 which target JAKs and cytokine receptors, SOCS4 has distinct substrates:

Regulation of SOCS4 Expression

SOCS4 expression is transcriptionally regulated:

Positive Regulators:

• IFN-α/β signaling (STAT1-dependent)
• Growth hormone signaling
• p53 tumor suppressor

• DNA methylation (promoter silencing)
• Histone deacetylation
• Oncogenic transcription factors (c-Myc, Ras)

Evolutionary Context

SOCS Family Evolution

The SOCS family evolved from a common ancestor:

Conservation

SOCS4 is conserved across species:

• Human: 394 amino acids
• Mouse: 93% identity
• Zebrafish: 78% identity
• Drosophila: Homolog (SOCS16D)

Research Tools

Antibodies and Reagents

Model Systems

• Cell lines: A549 (lung), MCF-7 (breast), SGC-7901 (gastric)
• Animal models: SOCS4 knockout mice, xenografts
• Organoids: Patient-derived tumor organoids

Therapeutic Development

Preclinical Strategies

SOCS4 restoration approaches in development:

Clinical Trials

No SOCS4-specific trials yet, but related approaches:

• JAK inhibitors in neuroinflammation
• STAT3 inhibitors in cancer
• Epigenetic therapy trials

Challenges

• Delivery to specific tissues
• Achieving sustained expression
• Avoiding off-target effects
• Combination with existing therapies

Future Perspectives

Biomarker Development

SOCS4 as a biomarker:

• Diagnostic: Tumor vs. normal tissue
• Prognostic: Survival prediction
• Predictive: Therapy response
• Monitoring: Disease progression

Personalized Medicine

SOCS4 status informs treatment:

• High SOCS4: Better prognosis
• Low SOCS4: Consider restoration therapy
• Methylated promoter: Epigenetic therapy

Emerging Research Areas

• Single-cell analysis of SOCS4
• Spatial transcriptomics
• SOCS4 in immunotherapy response
• Neuroinflammation modulation

See Also

• [JAK-STAT Signaling](/mechanisms/jak-stat-signaling-neurodegeneration)
• [Cytokine Signaling](/mechanisms/cytokine-signaling)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Tumor Suppressor Genes](/entities/tumor-suppressor-genes)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: SOCS4](https://www.ncbi.nlm.nih.gov/gene/122829)
• [UniProt: SOCS4](https://www.uniprot.org/uniprot/Q9Y257)
• [OMIM: SOCS4](https://www.omim.org/entry/605801)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

References